A Dose-Optimization Study for the Initial Treatment of Dysplastic Barrett's Esophagus With trūFreeze™ Spray Cryotherapy

NATerminatedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

January 31, 2015

Conditions
Barrett's Esophagus
Interventions
DEVICE

trūFreeze™ Spray Cryotherapy

The trūFreeze™ System consists of a console containing a holding tank for medical grade liquid nitrogen and a spray tip CSATM Catheter. The physician uses the console to initiate and control the flow and duration of the cryogen spray. The liquid nitrogen is propelled through a spray CSATM Catheter to the selected site by pressure in the holding tank and freezing techniques are monitored by direct visualization with an endoscope. Once the freezing is completed, the cryogen flow is terminated and the thawing system may be engaged to allow accessory removal. If multiple cycles are used, thawing is initiated at the end of the procedure.

Trial Locations (6)

10032

Columbia University, New York

21201

University of Maryland, Baltimore

27599

University of North Carolina, Chapel Hill, Chapel Hil

29425

Medical University of South Carolina, Charleston

32224

Mayo Clinic Jacksonville, Jacksonville

44122

Ahuja/University Hospitals, Beachwood

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CSA Medical, Inc.

INDUSTRY